glp-1 news 2025 november trends 2025: real-world data, patient outcomes & future therapies GLP-1 Receptor Agonists and vision

In vitro, GLP-1GIPLani had indistinguishable effects on incretin receptor signalling compared with its GLP-1GIP co-agonist backbone, and this was verified by equal potentiation of glucose-stimulated insulin secretion in isolated mouse islets (Fig

If not addressed, stomach paralysis may lead to malnutrition, dehydration, and blood sugar complications

Physical activity plays a crucial role in promoting gut motility

GLP-1 drugs have become wildly popular as weight-loss medications, but with their increased use has come concern over the long-term safety of this class of drugs

Every year, the share of employers who cover GLP-1s for diabetes and/or obesity continues to grow

This behavior leads to mindless eating and can cause unnecessary weight accumulation